Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1247 of 5804
-
Magic mushroom therapy could ease persistent concussion symptoms
Symptom relief Recruiting nowThe goal of this randomized controlled trial is to evaluate the safety, feasibility, and efficacy of psilocybin assisted therapy as an intervention to reduce symptom burden in adult patients (aged 18-65) with persisting symptoms after concussion (PSaC). This trail will test the …
Phase: PHASE1 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Heart drug digoxin tested as potential ALS treatment
Disease control OngoingThis clinical trial is being conducted to learn about safety and tolerability of digoxin in ALS individuals. Additionally, this trial aims to better understand if digoxin has an effect on slowing neurodegeneration in ALS.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Caregiver massage app aims to soothe chemo nerve pain
Symptom relief Recruiting nowThis clinical trial assesses the impact of a family caregiver-delivered massage technique for use in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a common cancer treatment side effect that impairs quality of life and daily functioning. Aside fr…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New hope for psoriasis patients when first treatment fails
Disease control OngoingThis multicenter, randomized, double-blind, active-controlled study aims to evaluate the efficacy and safety of picankibart in Chinese patients with plaque psoriasis who demonstrated inadequate responses to interleukin-17 (IL-17) monoclonal antibody therapy and subsequently switc…
Phase: PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Virtual reality showdown: can shared VR worlds help Parkinson's patients move better?
Symptom relief Recruiting nowThis randomized controlled trial aims to compare the effectiveness of a Collaborative Virtual Reality Environment (CVE) and Non-Immersive Virtual Reality (NIVR) in the rehabilitation of patients with Parkinson's disease. Participants with mild to moderate disease severity will be…
Phase: NA • Sponsor: Superior University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could a sleep drug curb impulsivity in opioid recovery?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn about how certain medications used to treat insomnia (e.g., Lemborexant) impact sleep, mood, and behavior in men and women with Opioid Use Disorder who are taking prescribed buprenorphine. The main questions it aims to answer are: 1. W…
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Time-Restricted eating tested to cut heart risk in childhood cancer survivors
Disease control Recruiting nowThis study will look at whether motivational sessions (including regular calls with a trained health coach) in combination with time-restricted eating (TRE) is an effective way to achieve weight loss and lower cardiometabolic risk in adult survivors of childhood cancer. The resea…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New combo therapy aims to boost immune attack on Hard-to-Treat cancers
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of M5A-IL2 immunocytokine (M5A-ICK) combined with stereotactic body radiation therapy (SBRT) and to see how well they work in treating patients with colorectal cancer or xarcinoembryonic antigen (CEA) positive breast cance…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Zapping the Brain's fear center: a new hope for depression?
Symptom relief CompletedThe current investigation employs a directed neuromodulation technique, specifically targeting the right amygdala, to ascertain its therapeutic efficacy in managing depressive episodes. The intervention's safety and efficacy will be evaluated using an assessment incorporating dep…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Brain Implant's hidden impact on voice and swallowing in Parkinson's
Knowledge-focused Recruiting nowNearly one-million people in North America are now living with Parkinson's disease (PD), and that number is projected to rise to nearly 1.2 million by 2030. With advancements in neuromodulatory technologies, increasingly more of these individuals elect to undergo deep brain stimu…
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Can stem cell vesicles help rebuild brain blood vessels in moyamoya?
Disease control Recruiting nowMoyamoya disease is a cerebrovascular disease clinically characterized by chronic progressive stenosis or occlusion at the ends of bilateral internal carotid arteries and the origin of anterior cerebral arteries and middle cerebral arteries, followed by the formation of abnormal …
Phase: PHASE1 • Sponsor: Huaqiu Zhang • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug BDC-4182 targets stomach cancer by waking up the immune system
Disease control Recruiting nowA first-in-human study using BDC-4182 as a single agent in gastric and gastroesophageal cancers
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI vs. high blood pressure: smart software aims to personalize treatment
Disease control Recruiting nowThis trial is a prospective, multicenter, single-blind, three-arm parallel-group, cluster randomized controlled trial assessing the effectiveness and safety of two types of CDSS in primary care settings in China. Primary care sites are randomized to one of the intervention arms o…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New biosimilar aims to rival cosentyx for psoriasis
Disease control OngoingThe goal of this Phase 3 clinical trial is to compare efficacy and safety of CT-P55 with Cosentyx in patients with moderate to severe plaque psoriasis
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cocktail of drugs targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThe purpose of this clinical trial is to explore the efficacy and safety of Regorafenib combined with Toripalimab and Paclitaxel-albumin in patients as the third line treatment for patients with unresectable or metastatic pancreatic cancer.The main question it aims to answer is: …
Phase: PHASE1, PHASE2 • Sponsor: Junjie Hang • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Scientists hunt for clues to drug resistance in tough colorectal cancer
Knowledge-focused Recruiting nowThis study prospectively investigates the molecular mechanisms of primary and acquired resistance to standard-of-care BRAF V600E-directed therapy in patients with metastatic colorectal cancer and aims to pre-clinically develop novel strategies to reverse therapy resistance. Clini…
Sponsor: Swiss Cancer Institute • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Simple blood test could spot cancer early
Diagnosis Recruiting nowThis prospective phase II trial aims to evaluate the diagnostic performance of multi-cancer epitope diagnosis in monocyte (EDIM) based blood test PanTum detect test for early detection of individuals with pre-malignant or malignant lesion(s). The intervention in this trial is th…
Phase: NA • Sponsor: Comenius University • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New combo aims to tackle lung cancer after immunotherapy fails
Disease control Recruiting nowThis is a multicenter Phase I/II study for patients with advanced non-small cell lung cancer who have failed PD-1/L1 therapy, aiming to evaluate the safety of ZG005 in combination with Gecacitinib in this population, as well as the preliminary efficacy of this combination regimen…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could moringa leaf powder help pregnant women with anemia?
Disease control OngoingTitle: The Effect of Moringa Oleifera Leaf Micronized Powders on Hematological Profile, Hepcidin, and Cytokines (IL-1 and IL-6) in Pregnant Women with Iron Deficiency Anemia Study Description: Iron deficiency anemia is one of the most common health problems affecting pregnant w…
Phase: NA • Sponsor: Universitas Padjadjaran • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Jun 26, 2026 13:03 UTC